CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics
Ng V, Seth A, Alkhalil I, Grube E, Morice M, Mao V, Deible R, Sudhir K, Lansky A. CRT-200.54 Evaluation of 2-year Clinical Outcomes From Post-market Trials With Everolimus-eluting Cobalt Chromium Stents in Diabetics. JACC Cardiovascular Interventions 2016, 9: s20. DOI: 10.1016/j.jcin.2015.12.086.Peer-Reviewed Original Research